company background image
688315 logo

Novogene SHSE:688315 Stock Report

Last Price

CN¥10.69

Market Cap

CN¥4.4b

7D

-0.7%

1Y

-56.6%

Updated

13 Jul, 2024

Data

Company Financials +

Novogene Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Novogene
Historical stock prices
Current Share PriceCN¥10.69
52 Week HighCN¥27.43
52 Week LowCN¥9.94
Beta0.69
11 Month Change-13.79%
3 Month Change-19.44%
1 Year Change-56.63%
33 Year Change-73.93%
5 Year Changen/a
Change since IPO-60.99%

Recent News & Updates

Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%

Jun 07
Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%

Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook

Apr 17
Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook

Recent updates

Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%

Jun 07
Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%

Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook

Apr 17
Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook

Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)

Mar 25
Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)

Shareholder Returns

688315CN Life SciencesCN Market
7D-0.7%0.8%1.2%
1Y-56.6%-39.7%-18.5%

Return vs Industry: 688315 underperformed the CN Life Sciences industry which returned -39.7% over the past year.

Return vs Market: 688315 underperformed the CN Market which returned -18.5% over the past year.

Price Volatility

Is 688315's price volatile compared to industry and market?
688315 volatility
688315 Average Weekly Movement6.1%
Life Sciences Industry Average Movement6.4%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 688315's share price has been volatile over the past 3 months.

Volatility Over Time: 688315's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20112,144Ruiqiang Liwww.novogene.com

Novogene Co., Ltd. provides genomic services and solutions worldwide. The company offers genomic solutions, such as human genome sequencing, gene regulation, single cell sequencing, animal and plant solutions, and microbial genome sequencing; and cancer genomic profiling, whole exome sequencing, and FFPE RNA sequencing, as well as clinical-grade whole exome sequencing services. It also provides NovoFocus CR, a gene coverage for hereditary cancer screening; and NovoNeoantigen, a bioinformatics pipeline for the identification of cancer neoantigens with whole exome sequencing and whole transcriptome sequencing data from paired tumor-normal samples.

Novogene Co., Ltd. Fundamentals Summary

How do Novogene's earnings and revenue compare to its market cap?
688315 fundamental statistics
Market capCN¥4.41b
Earnings (TTM)CN¥182.87m
Revenue (TTM)CN¥2.03b

24.1x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688315 income statement (TTM)
RevenueCN¥2.03b
Cost of RevenueCN¥1.17b
Gross ProfitCN¥861.96m
Other ExpensesCN¥679.09m
EarningsCN¥182.87m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 15, 2024

Earnings per share (EPS)0.44
Gross Margin42.46%
Net Profit Margin9.01%
Debt/Equity Ratio0.04%

How did 688315 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

10%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.